Financhill
Buy
52

AXGN Quote, Financials, Valuation and Earnings

Last price:
$15.25
Seasonality move :
9.34%
Day range:
$14.37 - $15.28
52-week range:
$5.55 - $17.23
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.67x
P/B ratio:
6.76x
Volume:
307.6K
Avg. volume:
355.3K
1-year change:
77.76%
Market cap:
$672M
Revenue:
$159M
EPS (TTM):
-$0.32

Analysts' Opinion

  • Consensus Rating
    Axogen has received a consensus rating of Buy. The company's average rating is a Buy based on 4 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $18.00, Axogen has an estimated upside of 17.88% from its current price of $15.27.
  • Price Target Downside
    According to analysts, the lowest downside price target is $17.00 representing 100% downside risk from its current price of $15.27.

Fair Value

  • According to the consensus of 4 analysts, Axogen has 17.88% upside to fair value with a price target of $18.00 per share.

AXGN vs. S&P 500

  • Over the past 5 trading days, Axogen has underperformed the S&P 500 by -6.96% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Axogen does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Axogen has grown year-over-year revenues for 10 quarters straight. In the most recent quarter Axogen reported revenues of $48.6M.

Earnings Growth

  • Axogen earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Axogen reported earnings per share of -$0.04.
Enterprise value:
694.7M
EV / Invested capital:
--
Price / LTM sales:
3.67x
EV / EBIT:
--
EV / Revenue:
3.84x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-70.18x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
405.10x
Gross Profit (TTM):
$142.4M
Return On Assets:
-7.46%
Net Income Margin (TTM):
-7.91%
Return On Equity:
-14.85%
Return On Invested Capital:
-9.99%
Operating Margin:
-0.65%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Income Statement
Revenue $134M $152.3M $180.9M $41.3M $48.6M
Gross Profit $110.5M $119.9M $142.4M $31.7M $36.4M
Operating Income -$29.5M -$23.9M -$8.5M -$4M -$316K
EBITDA -$23.4M -$17.4M $1.7M -$1.9M $2M
Diluted EPS -$0.67 -$0.56 -$0.32 -$0.10 -$0.04
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Balance Sheet
Current Assets $140M $135M $102.5M $87.4M $86.3M
Total Assets $193.9M $210M $195.5M $194.6M $192M
Current Liabilities $18.8M $23.4M $23.5M $26.6M $23M
Total Liabilities $72.2M $94.7M $94.1M $96.8M $92.6M
Total Equity $121.7M $115.3M $101.4M $97.8M $99.4M
Total Debt $31.8M $46.2M $45.5M $46.4M $47.3M
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Cash Flow Statement
Cash Flow Operations -$18.9M -$4.1M -$4.4M $1.6M $3.9M
Cash From Investing -$15.6M $18.3M -$9.8M $6M -$5M
Cash From Financing $2M $2.3M $1.7M $5K $572K
Free Cash Flow -$40.7M -$24.1M -$9.9M -$2.3M $2.8M
AXGN
Sector
Market Cap
$672M
$47.1M
Price % of 52-Week High
88.62%
48%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.74%
1-Year Price Total Return
77.77%
-33.14%
Beta (5-Year)
1.015
0.754
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Sell
Level $15.83
200-day SMA
Buy
Level $10.73
Bollinger Bands (100)
Buy
Level 12.82 - 15.08
Chaikin Money Flow
Buy
Level 19.6M
20-day SMA
Sell
Level $15.46
Relative Strength Index (RSI14)
Buy
Level 50.56
ADX Line
Sell
Level 31.98
Williams %R
Neutral
Level -60.6811
50-day SMA
Buy
Level $14.46
MACD (12, 26)
Buy
Level 0.32
25-day Aroon Oscillator
Buy
Level 24
On Balance Volume
Neutral
Level 44.1M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (0.5885)
Sell
CA Score (Annual)
Level (-0.5743)
Buy
Beneish M-Score (Annual)
Level (-2.6509)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (1.7551)
Buy
Piotroski F Score (Annual)
Level (4)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (5)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

Stock Forecast FAQ

In the current month, AXGN has received 4 Buy ratings 0 Hold ratings, and 0 Sell ratings. The AXGN average analyst price target in the past 3 months is $18.00.

  • Where Will Axogen Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Axogen share price will rise to $18.00 per share over the next 12 months.

  • What Do Analysts Say About Axogen?

    Analysts are divided on their view about Axogen share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Axogen is a Sell and believe this share price will drop from its current level to $17.00.

  • What Is Axogen's Price Target?

    The price target for Axogen over the next 1-year time period is forecast to be $18.00 according to 4 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is AXGN A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Axogen is a Buy. 4 of 4 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of AXGN?

    You can purchase shares of Axogen via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Axogen shares.

  • What Is The Axogen Share Price Today?

    Axogen was last trading at $15.25 per share. This represents the most recent stock quote for Axogen. Yesterday, Axogen closed at $15.27 per share.

  • How To Buy Axogen Stock Online?

    In order to purchase Axogen stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is ARK Next Generation Internet ETF a Good Investment?
Is ARK Next Generation Internet ETF a Good Investment?

The ARK Next Generation Internet ETF looks like a pretty…

Why Is Marvell Stock Up?
Why Is Marvell Stock Up?

Semiconductor and data infrastructure company Marvell Technology (NASDAQ:MRVL) absolutely trounced…

Why Is General Electric Stock Going Up?
Why Is General Electric Stock Going Up?

General Electric Company, doing business these days as GE Aerospace…

Stock Ideas

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Sell
44
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 36x

Alerts

Sell
1
IONQ alert for Jan 10

IonQ [IONQ] is up 2.25% over the past day.

Sell
40
QMCO alert for Jan 10

Quantum [QMCO] is down 0.29% over the past day.

Sell
47
MATW alert for Jan 10

Matthews International [MATW] is down 3.25% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock